Modeling the Binding Kinetics of Bispecific Antibodies under the Framework of a Minimal Human PBPK Model Poster Modeling the Binding Kinetics of Bispecific Antibodies under the Framework of a Minimal Human PBPK Model Certara2014 年 5 月 19 日
Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science Publication Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science Fourteen drugs have been removed from the market worldwide because they cause torsade de pointes.…Certara2014 年 5 月 1 日
Changes in Individual Drug-independent System Parameters during Virtual Pediatric Pharmacokinetic Trials: Introducing Time-varying Physiology into a Pediatric PBPK Model Publication Changes in Individual Drug-independent System Parameters during Virtual Pediatric Pharmacokinetic Trials: Introducing Time-varying Physiology into a Pediatric PBPK Model Although both POPPK and physiologically based pharmacokinetic (PBPK) models can account for age and other covariates within…Certara2014 年 5 月 1 日
Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials Publication Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials Model-based drug development in oncology is still lagging despite a good momentum in the clinical…Certara2014 年 4 月 1 日
Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients with Non-small Cell Lung Cancer Based on MONET1 Study Results Publication Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients with Non-small Cell Lung Cancer Based on MONET1 Study Results The motesanib phase III MONET1 study failed to show improvement in overall survival (OS) in…Certara2014 年 4 月 1 日
Physiologically-based Pharmacokinetic Modeling Framework for Quantitative Prediction of an Herb–Drug Interaction Publication Physiologically-based Pharmacokinetic Modeling Framework for Quantitative Prediction of an Herb–Drug Interaction Herb–drug interaction predictions remain challenging. Physiologically based pharmacokinetic (PBPK) modeling was used to improve prediction…Certara2014 年 3 月 26 日
Population Pharmacokinetics of Azithromycin in Whole Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells in Healthy Adults Publication Population Pharmacokinetics of Azithromycin in Whole Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells in Healthy Adults Azithromycin's extensive distribution to proinflammatory cells, including peripheral blood mononuclear cells (PBMCs) and polymorphonuclear cells…Certara2014 年 3 月 5 日
Impact of Electrocardiographic Data Quality on Moxifloxacin Response in Thorough QT/QTc Studies Publication Impact of Electrocardiographic Data Quality on Moxifloxacin Response in Thorough QT/QTc Studies Thorough QT studies are typically conducted for drugs with systemic bioavailability and include a positive…Certara2014 年 3 月 1 日
Electrocardiographic Data Quality in Thorough QT/QTc Studies Publication Electrocardiographic Data Quality in Thorough QT/QTc Studies Most drugs with systemic bioavailability have to undergo a thorough QT (TQT) study, which includes…Certara2014 年 3 月 1 日
In Vitro-In Vivo Extrapolation of Drug-induced Proarrhythmia Predictions at the Population Level Publication In Vitro-In Vivo Extrapolation of Drug-induced Proarrhythmia Predictions at the Population Level Drug cardiotoxicity is a serious issue for patients, regulators, pharmaceutical companies and health service payers…Certara2014 年 3 月 1 日